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In this project I sought to analyse the effects of different free fatty acids (FFAs) on INS-1E β-
cells. The saturated fatty acid palmitate is considered toxic whereas the monounsaturated 
fatty acid oleate is harmless. In my working hypothesis I assumed an additional protective 
effect of oleate when used in combination with palmitate. Furthermore I aimed to explore in 
detail the possible causes and signalling pathways responsible for apoptosis or sustained 
cell survival. I examined the Endoplasmic Reticulum (ER) stress response, called unfolded 
protein response (UPR), as one essential criterion deciding about cell death or life. Analysis 
of viability and apoptosis confirmed the deleterious effect of palmitate on INS-1E β-cells after 
24h of incubation. Oleate proved not to be harmful and even reversed the toxicity of 
palmitate. When the main components of the UPR were assessed using Western blot 
analyses and quantitative PCR was performed I found positive proof that palmitate activated 
the UPR and ultimately led to apoptosis. By contrast, oleate completely prevented UPR 
signalling. I conclude that oleate rescues INS-1E β-cells by inhibiting ER stress and its 




ATF4 activating-transcription-factor 4 
ATF6  activating-transcription-factor 6 
Bcl-2 B-cell lymphoma 2 
Bip/Grp78 immunoglobulin heavy-chain binding protein 
Chop C/EBP homologous protein 
DAG diacylglycerol 
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eIF2α eukaryotic initiation factor 2α  
ER endoplasmic reticulum 
ERAD Endoplasmic-reticulum-associated protein degradation 
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MUFA monounsaturated fatty acid 
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PERK protein-kinase-regulated-by-RNA-like-ER-associated-kinase 
SFA saturated fatty acid 
SERCA Sarcoplasmic/endoplasmic reticulum calcium ATPase 
TAG triacylglycerol 
UPR unfolded protein response 
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Xbp1 X-box-binding protein 1 
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1. Introduction 
 
1.1. Epidemiology and risk factors for type two diabetes mellitus (T2DM) 
Nowadays chronic diseases represent an increasing challenge for western public health 
services. Type 2 diabetes mellitus (T2DM) is one of these diseases that clearly illustrates the 
different problems that usually accompany chronic illnesses: limited curative treatment 
options, serious long-time complications and difficulties to motivate patients for therapy 
compliance and lifestyle changes. Today diabetes mellitus is a burden affecting around 366 
million people worldwide [1]. The majority suffers from T2DM as it accounts for 90-95% of 
diabetes whereas other forms represent only 5-10% [2, 3]. In this dissertation I will therefore 
limit my focus to T2DM. The International Diabetes Federation estimated the worldwide 
prevalence of diabetes at 8.3% in 2011 and predicted a rise to 9.9% in 2030 [1]. A study of 
the Robert-Koch-Institute, the “German Health Interview and Examination Survey for Adults” 
reported a lifelong prevalence of 7.4% in Germany in 2011 which is a rise of about 38% in the 
last decade [4]. But not only high-income countries are afflicted with diabetes. The strongest 
rise in prevalence has been predicted for low- and middle-income countries [1]. What are the 
factors triggering this growing epidemic? Age is a strong risk factor to develop diabetes and 
an aging population can explain a part of the increasing prevalence [5]. In Germany a full 1/3 
of the rise can be attributed to demographic aging [4]. A typical sedentary western lifestyle 
also raises the risk for diabetes [6, 7]. A positive family history of diabetes increases the risk 
approximately 2.5 fold and to an even higher extend if both parents are affected. The 
association between diabetes and family history is an independent risk factor which cannot 
be sufficiently explained by lifestyle and genetic characteristics [7]. A key element in the 
development of diabetes is obesity [8, 9]. Trends in diabetes are paralleled by an increasing 
number of obese and overweight subjects in all countries [10]. An additional risk of 7.3% to 
develop diabetes was calculated for every kilogram of weight gained [11]. Independently of 
weight gain an increase in abdominal fat resulted in an elevated risk [11]. Therefore the 
research on fat storage and mobilisation has received much attention as it seems to 
influence metabolic control. Free fatty acids (FFAs) could be part of the link between obesity 
and diabetes. Elevated plasma levels of circulating FFAs have been demonstrated in obese 
individuals compared to lean control subjects and are a risk factor for diabetes [12, 13]. An 
even further elevation of FFAs was also found in patients suffering from diabetes compared 
to obese non-diabetic patients [14, 15].  
1.2. Characterization of FFAs 
FFAs cannot be viewed as a uniform group but are often classified into saturated and 
unsaturated fatty acids. Saturated fatty acids display only single bonds between carbon 
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atoms whereas unsaturated fatty acids have at least one double bond. Palmitic acid (16:0) 
and oleic acid (18:1) are widely used to analyse the different metabolic effects of the two 
classes. Palmitic acid (CH3(CH2)14COOH) represents the main component of saturated fatty 
acids in human plasma and adipose tissue [16]. Its main sources are palm oil, butter, meat 
and dairy products. In contrast, oleic acid (CH3(CH2)7CH=CH(CH2)7COOH) as  
monounsaturated fatty acid is mostly found in olive oil, nuts and seeds. It is the most 
abundant fatty acid in human plasma and adipose tissue [16]. In the body FFAs serve as 
energy source in muscles, liver and heart. They are also used for the synthesis of hormones 
and the construction of cellular membranes. Exogenous dietary fats are hydrolysed and 
absorbed into mucosa cells where triacylglycerols (TAGs) are re-synthesised. These TAGs 
are assembled to chylomicrons and transported to muscle and fat cells. The lipoproteinlipase 
hydrolyses the TAGs and the FFAs are taken up by the cells. The liver is the principle side of 
endogenous fatty acid synthesis. Very-low-density lipoproteins (VLDLs) transport the fatty 
acids to the adipose tissue where they are stored as TAGs. These metabolic pathways are 
controlled by insulin which suppresses lipolysis in adipocytes and stimulates lipogenesis in 
the liver [17, 18].  
1.3. FFAs and the pathophysiology of T2DM 
What is so far known about the connection of FFAs and diabetes? Increased levels of FFAs 
are associated with impaired insulin sensitivity [19, 20]. This may in part be explained by 
ectopic fat storage in muscle and liver cells [21]. The body handles excess FFA supply by 
storing it as intramyocellular and intrahepatic triglycerides [22, 23]. Studies demonstrated 
that toxic intermediates such as diacylglycerol interfere with insulin signalling [24, 25]. As the 
muscle is responsible for 80% of insulin stimulated glucose uptake impaired signalling leads 
to disturbed insulin sensitivity [26]. In the liver Boden et al. demonstrated that infusion of 
FFAs abolished insulin mediated down regulation of endogenous glucose production and 
thereby contributed to insulin resistance [27]. FFA levels are increased in obesity [28]. In 
accordance, impaired insulin sensitivity has been shown in obese subjects compared to lean 
[29, 30]. However the majority of overweight subjects is metabolically healthy and never 
develops diabetes [31]. This discrepancy is explained by the findings of Kahn et al. who 
described the relation between insulin sensitivity and insulin secretion as hyperbolic function 
[29]. Insulin resistant subjects compensate by increasing insulin secretion. Only if β-cells fail 
to maintain high insulin secretion levels overt diabetes develops. In accordance, Butler et al. 
reported a reduced β-cell mass and an increase in apoptosis in pancreases of diabetic 
compared to non-diabetic subjects [32]. Saturated FFAs also seem to be involved in the 
induction of apoptosis in β-cells. What are the detailed mechanisms leading to β-cell death? 
Numerous studies over the last decades point to the importance of endoplasmic reticulum 
stress in the development of progressive β-cell loss.  
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1.4. Characterization of Endoplasmic reticulum (ER) stress and the 
unfolded protein response (UPR) 
The ER plays a critical role in β-cells as it is indispensable for insulin secretion. During 
translation preproinsulin is directed and inserted into the ER where it is further processed. In 
the lumen of the ER disulfide bond formation and correct protein folding of proinsulin is 
assured by the help of chaperones. Thereafter, insulin is transported to the Golgi apparatus 
where it is further processed and secreted into vesicles [17]. Thus, the ER is essential to 
cope with increased insulin demand. When stress, like an accumulation of misfolded 
proteins, perturbs homoeostasis in the ER, a signalling cascade called the unfolded protein 
response (UPR) is activated. The task of the UPR is to assure proper function of the ER or to 
induce apoptosis if stress is overwhelming.  
IRE1, ATF6 and PERK are the three main transmembrane proteins that mediate the UPR. 
They are inactive when the chaperone Bip binds to their luminal side but increasing stress in 
the ER triggers dissociation of Bip [33, 34]. 
 
Chaperones, ERAD, Apoptosis (Chop) 
Xbp1 ATF6 ATF4 
Figure 1 The UPR 
Modified and taken from: Protein quality control—linking the unfolded protein response to 
disease 
Cyr, Douglas M.; Hebert, Daniel N. EMBO Rep (EMBO reports), 2009; 11: 1206–1210 
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1.4.1. PERK  
Dissociation of Bip from the luminal side of PERK (protein-kinase-regulated-by-RNA-like-ER-
associated-kinase) leads to its autophosphorylation and activation. Subsequently, PERK 
phosphorylates eIF2α (eukaryotic initiation factor 2α). Phosphorylated eIF2α inhibits global 
protein translation and thereby decreases workload in the ER. This protects the β-cell against 
ER stress. However, a prolonged phosphorylation of eIF2α acts proapoptotic in increasing 
the transcription of the proapoptotic transcription factor Chop. The mechanisms by which 
Chop induces apoptosis are not yet fully elucidated. It is known that Chop decreases the 
expression of the antiapoptotic Bcl-2 and in return favours the expression of apoptotic genes. 
The PERK pathway is the strongest activator of Chop. 
1.4.2. IRE1 
When Bip dissociates from IRE1 (inositol-requiring-enzyme 1) it is activated by dimerization 
and autophosphorylation. IRE1 cleaves Xbp1 (X-box-binding protein 1) mRNA producing an 
alternatively spliced variant. This spliced form of Xbp1 functions as an active transcription 
factor and upregulates gene expression of ER chaperones. Spliced Xbp1 also enhances the 
expression of genes involved in ER associated protein degradation (ERAD) thereby 
increasing ER folding capacity and reducing the load of misfolded proteins. IRE1 also 
mediates the breakdown of mRNA destined for the ER. This effect has especially been 
described for proinsulin mRNA [35]. By these mechanisms the IRE1 pathway tends to 
decrease ER stress. But IRE1 hyperactivation can also lead to apoptosis by activating Chop. 
1.4.3. ATF6 
When Bip dissociates, ATF6 (activating-transcription-factor 6) transfers to the Golgi 
apparatus, where it is cleaved for activation. The cytoplasmic fragment acts as a nuclear 
transcription factor which enhances expression of ER chaperones. The ATF6 pathway 
overlaps with the function of Xbp1.  
In summary, the UPR attempts to handle increased ER stress by (1) increasing ER folding 
capacity through enhanced expression of chaperones, (2) intensified degradation of 
misfolded proteins by ERAD, (3) reduced workload in the ER by limited protein translation 
and mRNA degradation. If all these mechanisms fail to reduce stress, chronic hyperactivation 
of the UPR leads to apoptosis. 
1.5. The UPR in the development of diabetes 
The importance of the UPR for the development of diabetes is highlighted by several studies 
confirming increased ER stress markers in islets of diabetic humans and animal models. 
Huang et al. described a more frequent pattern of nuclear Chop in diabetic islets compared 
to non-diabetic [36]. Laybutt et al. reported increased splicing of Xbp1 and higher levels of 
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phosphor-eIF2α in islets of diabetic mice compared to controls. They also demonstrated 
increased chaperone levels and diminished concentrations of the antiapoptotic protein Bcl-2 
in islets of diabetic subjects compared to non-diabetic [37]. The Akita mice carry a missense 
mutation in the gene encoding insulin 2 which leads to misfolded proinsulin and increased 
ER stress. Consequently, Akita mice show elevated levels of Chop and Bip and develop 
diabetes [38]. Interestingly, Stoy et al. identified the same mutation in children suffering from 
neonatal diabetes [39]. Another mouse model demonstrated the importance of the PERK 
pathway for metabolic adaptation. Mice with a heterozygous mutation in the gene for eIF2α 
became diabetic when challenged with a high fat diet. Scheuner et al. reported distended ER 
compartments in β-cells of these mice. This structural alteration is probably due to 
accumulation of unfolded proinsulin in complex with Bip which leads to ER stress [40]. This 
emphasizes the importance of eIF2α signalling to attenuate protein translation and to protect 
the ER from overload in situations of high insulin demand.  
2. The research project 
2.1. Background and Aim 
7.2% or rather 4.6 million people in Germany are diagnosed with diabetes and the number 
will increase in the future [4]. Further insight into the mechanisms leading to diabetes is 
needed to provide effective therapy and prevention strategies. As described above, elevated 
FFAs could be a factor contributing to the development of diabetes. They have been reported 
to be one causal factor of insulin resistance [19]. Maedler et al. demonstrated that incubation 
with the saturated fatty acid palmitate induced apoptosis in human islets. In contrast, the 
treatment with the monounsaturated fatty acid oleate did not result in increased apoptosis but 
was even able to prevent the toxic effects of palmitate [41]. The aim of this study was to 
further address the different effects of saturated and unsaturated fatty acids on β-cells and 
the underlying mechanisms. Increased ER stress is an interesting candidate to explain the 
toxic effects of saturated fatty acids. I hypothesized that palmitate leads to β-cell apoptosis 
by stimulating the unfolded protein response and that oleate can rescue β-cells by 
counteracting this activation.  
In summary, I wanted to answer the following questions: 
1. Does oleate protect INS-1E β-cells from palmitate-induced apoptosis? 
2. Does palmitate activate the UPR? 
3. Can oleate counteract the induction of the UPR? 
4. Do FFAs modify chaperones levels?  
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2.2. Methods 
The validated rat insulinoma cell line INS-1E was used as a β-cells model. The cells were 
incubated with palmitate [0.5mM], oleate [1mM] and the combination of both [0.5mM/1mM] 
for a period of 1h, 6h and 24h. A mixture of the chemotherapeutics camptothecin [2µM] and 
etoposide [85µM] was employed as positive control for apoptosis. Thapsigargin [1µM] is 
known to cause ER stress by inhibiting the ER calcium pump SERCA thereby preventing 
calcium uptake in the ER. This leads to depletion of ER calcium stores and induces the UPR 
[42]. Thapsigargin was therefore applied as positive control for ER stress. Viability was 
measured using a commercially available WST-1 assay. Apoptosis was determined by 
staining cells with a FITC-AnnexinV (An) and propidium iodide (PI) staining kit followed by 
flow cytometric analysis. Apoptosis was measured by counting the An-positive and double-
stained An/PI-positive cells.  
Activation of the unfolded protein response was measured with the help of Western Blot 
analyses. Cells were incubated as described above and protein levels of eIF2α and its 
phosphorylated form (PeIF2α) were examined. To analyse changes in chaperone levels Bip 
was measured. The images were densitometrically evaluated using ImageJ software.  
The mRNA expression of further chaperones (Calnexin, Grp94, Pdi) and the proapoptotic 
transcription factor Chop was determined by qPCR. To evaluate splicing of Xbp1 I used an 
elegant method described by Toda et al. [43]. After amplification of Xbp1 mRNA the product 
was digested and the fragments separated by electrophoresis. This enabled me to reliably 
distinguish between the spliced and unspliced variant. A list of all primers used is attached in 
the Appendix. 
Triglyceride storage was detected by Nile red staining and visualised using fluorescence 
microscopy. Glucose stimulated insulin secretion of INS-1 cells was studied with a 
commercial insulin ELISA. 
2.3. Results 
In accordance with other studies palmitate proved to be toxic to INS-1E β-cells. 24h 
incubation with palmitate [0.5mM] significantly reduced viability (-34.6±7.2%) compared to 
controls (Appendix Figure 1A). In contrast, oleate [1mM] did not decrease viability but in 
combination with palmitate [0.5mM/1mM] completely abolished the deleterious effects of 
palmitate (Appendix Figure 1A). The results obtained for viability match well with the data for 
apoptosis. Palmitate induced apoptosis after 24h incubation (+39.6±8.6%) compared to 
controls whereas oleate did not. The combination of both prevented the destructive effects of 
palmitate and reduced apoptosis to basal levels (Appendix Figure 1B). Interestingly, 6h 
incubation with free fatty acids did neither have an impact on viability nor apoptosis (data not 
shown).  
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As previously demonstrated 24h incubation with palmitate also impaired the ratio of glucose 
stimulated insulin secretion (GSIS) to basal insulin secretion in INS-1 cells [41, 44]. However, 
cells stimulated with oleate or the combination preserved a stimulatory index similar to 
controls (Appendix Figure 6).  
One aim of this study was to investigate whether or not the opposite effects of palmitate and 
oleate are mediated by differences in UPR activation. I therefore examined the main 
pathways of the ER stress response. Phosphorylation of eIF2α was measured by Western 
Blot analysis. 6h and 24h incubation with palmitate raised phosphorylation of eIF2α to 
2.1±0.2 fold and to 1.4±0.2 fold, respectively (Appendix Figure 2A). The same effect was 
seen when cells were stimulated with thapsigargin [1µM] which is known to cause ER stress. 
In contrast, incubation with oleate did not alter the phosphorylation state of eIF2α. The 
combination of palmitate and oleate could even prevent increased phosphorylation of eIF2α 
(Appendix Figure 2A). 
Similar results were obtained when splicing of Xbp1 mRNA was examined. Treatment with 
oleate did not enhance splicing of Xbp1 whereas 24h incubation with palmitate produced a 
considerably higher amount of spliced Xbp1 mRNA (8.2±0.4 fold). The combination of 
palmitate and oleate in turn showed splicing rates comparable to controls (Appendix Figure 
2B). 
Interestingly, chaperone expression of Bip, Grp94, Pdi and Calnexin was not influenced by 
free fatty acid treatment (Appendix Figure 3, 4). In line with the results gained for apoptosis 
analysis, cells treated with palmitate for 24h showed significantly enhanced mRNA 
expression levels of the proapoptotic transcription factor Chop (2.8±0.5 fold) (Appendix 
Figure 4D). Again, the combination counteracted the effects of palmitate maintaining Chop 
mRNA expression at basal level. Incubation with oleate alone did not induce Chop 
expression. 
To visualize triglyceride storage Nile red staining of INS-1E β-cells was performed. Cells 
incubated with oleate or the combination presented more lipid droplets whereas palmitate-
treated cells showed a diffuse pattern of staining (Appendix Figure 5). 
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4.1. Conclusion and discussion 
Especially societies with a so called western lifestyle are afflicted by diabetes and obesity. 
The association between the two diseases cannot be doubted but the causes and the 
pathophysiology linking obesity and diabetes remain obscure. Elevated levels of free fatty 
acids in obese patients could be one factor contributing to the development of diabetes. It 
has been demonstrated that especially saturated fatty acids like palmitate can lead to β-cell 
apoptosis. Interestingly, the adverse effect is described for monounsaturated fatty acids like 
oleate [41, 44]. The aim of this research project was to verify or confute these postulated 
effects and elucidate the mechanisms responsible for the different effects observed. I 
hypothesized that oleate can counteract the toxicity of palmitate by down regulating the UPR. 
I demonstrated that palmitate induced apoptosis in INS-1E β-cells and that this detrimental 
effect was completely abolished by the addition of oleate. Furthermore, I could show that 
palmitate induced phosphorylation of eIF2α and splicing of Xbp1. Thus, I concluded that 
palmitate induced ER stress and activated the UPR. Oleate in contrast was able to inhibit 
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UPR activation when combined with palmitate. Interestingly, although chaperones are 
described to be downstream targets of the UPR [33], they were not altered by thapsigargin or 
palmitate treatment despite clear activation of the UPR. As suggested by several other 
studies [45, 46] I also propose that there has to be an additional unknown factor in the UPR 
influencing chaperone transcription. The importance of Chop for the induction of apoptosis 
through ER stress has been shown in animal models [38]. I also measured increased levels 
of Chop mRNA after 24h of palmitate treatment which correlates well with the data for 
apoptosis. In line with the unchanged viability and cell survival oleate did not induce Chop 
expression, but in combination with palmitate kept Chop at basal levels. I could demonstrate 
that only prolonged ER stress induced apoptosis in INS-1E β-cells as UPR makers were 
enhanced already at 6h of palmitate treatment but apoptosis did not start until 24h of 
palmitate treatment. One hypothesis to explain the different potential of saturated and 
unsaturated fatty acids to activate the UPR states that palmitate alters the membrane 
composition of the ER [47, 48]. Biophysical properties of membranes greatly depend on their 
degree of saturation. Membranes with a higher amount of unsaturated fatty acids are more 
fluid as the double bonds permit greater flexibility. By affecting transmembrane proteins and 
receptors the membrane composition strongly influences cell function [49]. Recently, Volmer 
et al. proved that palmitate can directly activate PERK and IRE1 without the help of Bip as 
these two transmembrane proteins sense changes in membrane characteristics [50]. I 
demonstrated that cells treated with oleate presented more lipid droplets in the cytoplasm 
after Nile red staining (Appendix Figure 5A) whereas palmitate-incubated cells showed a 
diffuse staining pattern (Appendix Figure 5B). Other studies characterized these stained 
structures and confirmed them to be dilated ER [47, 51]. When oleate was added, more lipid 
droplets were visualised (Appendix Figure 5C). I assumed that oleate partly channels 
palmitate away from the ER storing it in non-toxic triacylglycerides in cytoplasmic lipid 
droplets. The importance of membrane composition and saturation has also been 
demonstrated in vivo. Jocken et al. reported a negative correlation between insulin sensitivity 
and the amount of saturated DAG in muscle membranes [14]. Vessby et al. also showed a 
negative relationship between the amount of palmitate in muscle phospholipids and insulin 
sensitivity [20]. Weijers et al. hypothesized that a higher degree of saturation and thus 
inflexibility could lead to difficulties in the insertion of glucose transporters thereby promoting 
insulin resistance [49]. In future studies it would be interesting to address the influence of 
FFAs on the ER membrane composition in human islets.  
Another most interesting question remains: Can our results gained mostly in cell studies be 
transferred to the human context? Can any consequences for the therapy or prevention of 
diabetes be derived? In the KANWU study 162 subjects received different isocaloric diets. An 
improvement in insulin sensitivity was seen when monounsaturated fatty acids were 
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substituted for saturated [52]. Similar results were obtained by Pérez-Jiménez et al. who 
described decreased insulin sensitivity during a diet rich in saturated fatty acids compared to 
a diet rich in monounsaturated fatty acids [53]. Several studies confirmed the beneficial 
effects of a Mediterranean diet compared to typical western style food. The Mediterranean 
diet is characterized by a high intake of olive oil, fruits, legumes, fish and small use of animal 
fat, meat and dairy products. The ratio of unsaturated to saturated fatty acids is much higher 
in the Mediterranean diet as olive oil contains an especially large amount of unsaturated fatty 
acids whereas meat is rich in saturated fatty acids. The InterAct Project with a large number 
of participants reported a slight risk reduction of diabetes for individuals consuming a 
Mediterranean diet. Thereby most of the effects could be attributed to a high olive oil intake 
and moderated alcohol and meat consumption [54]. In a large Spanish cohort a reduced 
incidence of diabetes through Mediterranean Diet was detected even for subjects at high risk 
for diabetes [55]. A study of Mozaffarian et al. emphasized the positive influence of olive oil 
compared to butter for the prevention of diabetes [56]. In summary, there is growing evidence 
that unsaturated fatty acids like oleate can prevent the development of diabetes in humans 
when substituted for saturated fatty acids like palmitate. Their role should be further 
characterized to develop effective therapy and prevention strategies against diabetes. 
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6. Appendix 
 Figures as used in the publication 
 
INS-1E β-cells were treated with serum free medium (SFM), palmitate (Pal) [0.5mM], oleate 
(Ol) [1mM] or the combination of both (Pal+Ol) [0.5mM/1mM], thapsigargin (Tg) [1µM] and 
camptothecin [2µM] and etoposide [85µM] (C/E) for 24h. A) Viability was determined by 
WST-1 assay and B) apoptosis was determined as Annexin-positive and double-stained 
Annexin/Propidium Iodide positive cells by flow cytometric analysis. The results are shown in 
arbitrary units (a.u.). The data represent four to seven independent experiments performed 
sixfold (WST) or in duplicates (apoptosis) shown as means±SEM *p<0.05; **p<0.01; 
***p<0.001 compared to control, §§p<0.01 §§§p<0.001 compared to palmitate. 
Appendix Figure 1 Oleate rescues INS-1E β-cells form palmitate-induced apoptosis 
and restores viability 
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Western Blot analyses of eIF2α and phosphor-eIF2α were performed after 1h, 6h and 24h 
incubation with serum free medium (SFM), palmitate (Pal) [0.5mM], oleate (Ol) [1mM] and 
the combination (Pal+Ol) [0.5mM/1mM]. Thapsigargin (Tg) [1µM] at 1h represents the 
positive control for ER stress. One representative blot out of 4 independent experiments is 
shown. Blots were analysed densitometrically and normalised to GAPDH and the mean of 
SFM at 1h which was set 1. Results are shown as means±SEM *p<0.05; **p<0.01 compared 
to control.  
Appendix Figure 2A Palmitate-induced phosphorylation of eIF2α is counteracted by 
oleate 
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Xbp1 mRNA was amplified after 1h, 6h and 24h treatment with serum free medium (SFM), 
palmitate (Pal) [0.5mM], oleate (Ol) [1mM], the combination (Pal+Ol) [0.5mM/1mM] and 
thapsigargin (Tg) [1µM]. The product was digested with PstI. The unspliced (non-stressed) 
variant of Xbp1 results in two smaller fragments of 311bp and 141bp (Xbp1u) whereas the 
spliced (stressed) form is larger with 426bp (Xbp1s). GAPDH was used as loading control. 
The picture is one representative result out of three independent experiments. The blots were 
analysed densitometrically and are presented as fold over control with SFM at 1h set 1. 
Results are shown as means±SEM *p<0.05; **p<0.01; ***p<0.001 compared to control. 
Appendix Figure 3B Oleate prevents splicing of Xbp1 
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(A) Western Blot analysis of Bip was performed three times after 1h, 6h and 24h incubation 
with serum free medium (SFM), palmitate (Pal) [0.5mM], oleate (Ol) [1mM], the combination 
(Pal+Ol) [0.5mM/1mM] and thapsigargin (Tg) [1µM]. One representative blot is shown. (B) 
Bip mRNA expression was quantified by qPCR and normalised to Tbp. The expression is 
presented as fold over control with SFM at 1h set 1. The data represent means±SEM of three 
independent experiments. 
Appendix Figure 4 Incubation with palmitate and oleate does not influence Bip 
expression level 
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mRNA expression of (A) Grp94, (B) Pdi, (C) Calnexin and (D) Chop was analysed by qPCR. 
INS-1E β-cells were incubated for 1h, 6h and 24h with serum free medium (SFM), palmitate 
(Pal) [0.5mM], oleate (Ol) [1mM], the combination (Pal+Ol) [0.5mM/1mM] and thapsigargin 
(Tg) [1µM]. Tbp was used as housekeeping gene and data were referred to SFM at 1h set 1. 
Three to four independent experiments were performed and presented as means±SEM 
*p<0.05; **p<0.01; ***p<0.001 compared to control. 
Appendix Figure 4 Oleate antagonizes palmitate-mediated upregulation of Chop but 
does not alter chaperone levels 
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(A) oleate    (B) palmitate 
 
 
(C) palmitate and oleate 
After incubation cells were washed with PBS and subsequently incubated in darkness for 10 
minutes in PBS containing 10µg/ml Nile red. Again cells were washed in PBS and visualized 
using fluorescence microscopy (Keyence, Osaka, Japan). 
Nile red staining was performed after 24h incubation with (A) oleate (Ol) [1mM], (B) palmitate 
(Pal) [0.5mM] and the combination (C) (Pal+Ol) [0.5mM/1mM]. 25.1±0.9% of oleate treated 
cells showed lipid droplets whereas only 0.7±0.1% of palmitate treated cells displayed them. 
This rate ameliorated to 9.3±0.6% when cells were incubated with the combination of 
palmitate and oleate. The pictures are one representative result out of two independent 
experiments.  
Appendix Figure 5 Oleate promotes triglyceride storage in lipid droplets 
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* 
 
INS-1 cells, provided by Prof. Kathrin Mädler, University of Bremen, Germany, were 
stimulated with FFAs for 24h in RPMI medium (Gibco) supplemented with 5.5mM glucose. 
Afterwards medium was changed to RPMI medium supplemented with 3mM glucose for 1h. 
Then cells were pre-incubated for 1h in Krebs-Ringer-Hepes-Buffer (KRH-B) containing 
20mM Hepes, pH 7.4, 136mM NaCl, 4.7mM KCl, 1.25mM MgSO4, 1.25mM CaCl2, 3mM 
Glucose and 0.5% BSA. To measure acute insulin release cells were next incubated in KRH-
B containing 20mM glucose (stimulated) or 3mM glucose (basal). After 30 minutes the 
supernatant was withdrawn and analysed by an insulin Elisa (DRG, Marburg, Germany) 
according to manufactures instructions.  
After 24h incubation with serum free medium (SFM), palmitate (Pal) [0.5mM], oleate (Ol) 
[1mM] and the combination (Pal+Ol) [0.5mM/1mM] INS-1 cells were challenged with 3mM 
glucose or 20mM glucose, respectively and insulin secretion was determined. The insulin 
secretion was normalised to protein content and the stimulatory index was calculated. 
Palmitate showed a significantly reduced stimulatory index (-1.6±0.3 fold) compared to 
controls whereas the ratio remained unchanged in oleate treated cells. The combination 
restored the stimulatory index to baseline level. The data represent three independent 
experiments performed in duplicates shown as means ± SEM *p<0.05; compared to control. 
  
Appendix Figure 6 Palmitate diminishes glucose stimulated insulin secretion  
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Appendix Table 1 Sequences of Primer and Probes used for real-time PCR and 
TaqMan® 
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